Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Agecroft hires head of marketing for Europe

Tuesday, April 23, 2013
Opalesque Industry Update - Agecroft Partners, a global hedge fund consulting and third party marketing firm, has hired hedge fund marketing veteran Jim Sauls as Managing Director and Head of European Marketing. Jim brings over 20 years of institutional experience marketing hedge funds and derivative products on a global basis. Before Agecroft Partners Jim spent 10 years with Calatrava Securities, where he was Director of Marketing and CEO of their affiliated commodity pool operator. In these rolls he successfully raised capital from both European and US investors for multiple hedge fund managers and became intimately acquainted with all aspects of hedge fund operations, risk management, administration, compliance and reporting.

Prior to Calatrava, Jim held senior marketing and sales roles at both Fimat USA and Sanwa Futures, where he developed a strong understanding of global capital markets and international investors. Jim’s responsibilities will include heading Agecroft’s marketing efforts in Europe and assisting with due diligence on potential managers the firm may represent. Jim’s in-depth knowledge of a wide variety of investments strategies fits in with Agecroft Partners core philosophy of providing value in multiple ways to investors. This includes sharing advice regarding hedge fund asset allocation, manager selection, hedge fund industry trends, industry survey results and being the liaison between investors and the select hedge funds that have made it through their due diligence process.

“Jim is a wonderful addition to our firm. It is imperative that the members of our firm are highly technically competent. In addition, Jim has a reputation of having high integrity and strong ethical standards which are vital characteristics to build the long term reputation of our firm,” stated Agecroft Partners’ Managing Partner Don Steinbrugge.

Agecroft Partners was founded in 2007 with the thesis of creating an institutional quality hedge fund consulting and third party marketing firm. Since its founding, Agecroft Partners has been selected six years in a row as the Third Party Marketer of the Year by a major hedge fund industry organization. Agecroft utilizes an institutional due diligence process when evaluating hedge funds and represents less than 1% of the hedge funds that the firm analyzes.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its